1. Home
  2. IVA vs BVFL Comparison

IVA vs BVFL Comparison

Compare IVA & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • BVFL
  • Stock Information
  • Founded
  • IVA 2011
  • BVFL 1873
  • Country
  • IVA France
  • BVFL United States
  • Employees
  • IVA N/A
  • BVFL N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • BVFL Savings Institutions
  • Sector
  • IVA Health Care
  • BVFL Finance
  • Exchange
  • IVA Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • IVA 162.8M
  • BVFL 160.4M
  • IPO Year
  • IVA 2020
  • BVFL N/A
  • Fundamental
  • Price
  • IVA $3.90
  • BVFL $15.35
  • Analyst Decision
  • IVA Strong Buy
  • BVFL
  • Analyst Count
  • IVA 4
  • BVFL 0
  • Target Price
  • IVA $10.50
  • BVFL N/A
  • AVG Volume (30 Days)
  • IVA 23.7K
  • BVFL 23.1K
  • Earning Date
  • IVA 03-26-2025
  • BVFL 04-17-2025
  • Dividend Yield
  • IVA N/A
  • BVFL N/A
  • EPS Growth
  • IVA N/A
  • BVFL N/A
  • EPS
  • IVA N/A
  • BVFL 1.06
  • Revenue
  • IVA $14,591,573.00
  • BVFL $38,257,000.00
  • Revenue This Year
  • IVA $15.38
  • BVFL N/A
  • Revenue Next Year
  • IVA $24.22
  • BVFL N/A
  • P/E Ratio
  • IVA N/A
  • BVFL $14.44
  • Revenue Growth
  • IVA N/A
  • BVFL 1.89
  • 52 Week Low
  • IVA $1.53
  • BVFL $10.23
  • 52 Week High
  • IVA $4.05
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • IVA 69.86
  • BVFL 59.61
  • Support Level
  • IVA $3.69
  • BVFL $15.15
  • Resistance Level
  • IVA $4.05
  • BVFL $15.75
  • Average True Range (ATR)
  • IVA 0.25
  • BVFL 0.68
  • MACD
  • IVA 0.07
  • BVFL 0.17
  • Stochastic Oscillator
  • IVA 86.96
  • BVFL 81.98

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: